Recruiting
Phase 2

Cabozantinib in High Grade Neuroendocrine Neoplasms

Sponsor:

Washington University School of Medicine

Code:

NCT04412629

Conditions

High Grade Neuroendocrine Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cabozantinib

Blood for plasma biomarkers

Tissue biopsy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information